Earnings Feed
Start Free
LIPOSCIENCE INC·4

Feb 10, 3:11 PM ET

LIPOSCIENCE INC 4

4 · LIPOSCIENCE INC · Filed Feb 10, 2014

Insider Transaction Report

Form 4
Period: 2014-02-03
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-02-03−8,730→ 0 total
    Exercise: $2.50Exp: 2014-02-04→ Common Stock (8,730 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-03$2.50/sh+8,730$21,825→ 484,771 total
Holdings

  • Common Stock

    (indirect: By Spouse)
    180,167
Footnotes (1)
  • [F1]The option is fully vested and immediately exercisable. 50% of the shares underlying the option were vested upon issuance on February 4, 2004, with the remainder vesting in 24 equal monthly installments thereafter.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24
    doc1.txt

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY